Cian Healthcare
7.36
-0.15(-2.00%)
Market Cap₹18.80 Cr
PE Ratio75.20
IndustryHealthcare
Company Performance:
1D-2.00%
1M+43.19%
6M+119.05%
1Y+58.96%
5Y-33.09%
View Company Insightsright
More news about Cian Healthcare
05Aug 25
Cian Healthcare's Insolvency Resolution Plan Hearing Scheduled for August 6, 2025
Cian Healthcare Limited, under insolvency proceedings, announced that the National Company Law Tribunal (NCLT) will consider the approval of its resolution plan on August 6, 2025. The plan, approved by the Committee of Creditors on May 9, 2025, was submitted to NCLT on May 23, 2025. Resolution Professional Roshen Chordiya confirmed these developments in a regulatory filing, emphasizing the company's commitment to transparency and compliance with SEBI regulations.
Cian Healthcare
7.36
-0.15
(-2.00%)
1 Year Returns:+58.96%
Industry Peers
Sun Pharmaceutical
1,691.40
(+0.33%)
Divis Laboratories
6,656.50
(-3.30%)
Cipla
1,505.70
(+0.28%)
Torrent Pharmaceuticals
3,580.00
(+0.75%)
Dr Reddys Laboratories
1,205.40
(+0.02%)
Zydus Life Science
944.10
(+0.79%)
Mankind Pharma
2,261.80
(-2.05%)
Lupin
1,971.80
(+0.83%)
Alkem Laboratories
5,668.50
(+0.44%)
Aurobindo Pharma
1,123.80
(-1.47%)